The report provides companies with the necessary tools to improve their CRM programs by comparing their spending, staffing, structure, and strategies to those of top pharmaceutical companies.
Online PR News – 27-October-2009 – – As the pharmaceutical industry focuses on maximizing the lifetime value of customers and physicians, customer relationship management plays an increasingly important role. This study examines several top companies’ CRM strategies and tactics to discover and analyze CRM best practices. From structural involvement to overcoming inherent customer relationship management challenges, this study delves into the topics most relevant to pharmaceutical companies today.
Pharmaceutical Customer Relationship Management analyzes the inner-workings of initiative development, management and improvement processes. The report provides companies with the necessary tools to improve their CRM programs by comparing their spending, staffing, structure, and strategies to those of top pharmaceutical companies.
The report is broken down into four chapters:
* Structure and Resources - Learn how innovators develop champions for their CRM programs and rely on cross-functional cooperation. Benchmark investment levels and outsourcing strategies of various programs.
* Strategies and Tactics - Examine top CRM programs’ objectives and goals. Analyze companies’ efforts to measure customer lifetime value and return on investment.
* Challenges and Opportunities - Uncover some of the top challenges CRM programs face today and learn how to overcome these obstacles. Discover how the most successful programs rely on market research to develop customized messages and launch targeted efforts across various media channels.
* Real-World CRM Programs - Explore 13 real-world CRM programs’ resources, structure, development timeframes and media mixes.
Utilize this study to win additional resource support for your customer relationship management efforts. Apply findings from the study to streamline program management and improvement processes.
Companies Included in Report
Ajilon, ALK-Abello, Bristol-Myers Squibb, CPC Healthcare Communications, Harte-Hanks, Johnson & Johnson, Merck Sharp & Dohme, Novo Nordisk, Roche, Sanofi-Aventis, The Cement Works, Wyeth, A Top-Ten Pharmaceutical Company (name withheld)
For more information, please visit :
Or email us at firstname.lastname@example.org or call +919272852585